TELA Bio | SCHEDULE 13G:其他
TELA Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Laurence W. Lytton(9.9%)
TELA Bio | 10-Q:2024财年三季报
TELA Bio | 8-K:TELA Bio公布2024年第三季度财务业绩
TELA Bio | SC 13G:超过5%持股股东披露文件-Stonepine Capital Management, LLC(7.7%),Stonepine Capital, L.P(7.7%)等
TELA Bio | SC 13G/A:超过5%持股股东披露文件(修正)-EW Healthcare Partners Fund 2-UGP, LLC(10.44%),EW Healthcare Partners Fund 2-GP, L.P.(10.44%)等
TELA Bio | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(4.8%),OrbiMed Capital GP IV LLC(4.8%)
TELA Bio | 4:持股变动声明-高管 Cuca Roberto
TELA Bio | 4:持股变动声明-高管 Talmo Paul
TELA Bio | 4:持股变动声明-高管 KOBLISH ANTONY
TELA Bio | 4:持股变动声明-高管 Firestone Gregory A.
TELA Bio | 8-K:重大事件
TELA Bio | 424B5:募资说明书
TELA Bio | 424B5:募资说明书
TELA Bio | 8-K:重大事件
TELA Bio | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(8.6%),OrbiMed Capital GP IV LLC(8.6%)
TELA Bio | 10-Q:2024财年二季报
TELA Bio | 8-K:TELA Bio公布2024年第二季度财务业绩并重申2024年全年收入指导
TELA Bio | 4:持股变动声明-高管 Firestone Gregory A.
TELA Bio | SCHEDULE 13G:其他
暂无数据
暂无数据